NCT04699188: An ongoing trial by Novartis Pharmaceuticals
This trial is ongoing. It must report results 1 year, 9 months from now.
Full data
| Full entry on ClinicalTrials.gov | NCT04699188 |
|---|---|
| Title | A Phase Ib/II Open-label, Multi-center Dose Escalation Study of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Feb. 24, 2021 |
| Completion date | Jan. 25, 2027 |
| Required reporting date | Jan. 25, 2028, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | April 22, 2026 |
| Days late | None |